92 related articles for article (PubMed ID: 476617)
21. Repopulation in murine breast tumors during and after sequential treatments with cyclophosphamide and 5-fluorouracil.
Wu L; Tannock IF
Cancer Res; 2003 May; 63(9):2134-8. PubMed ID: 12727830
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of long-term chemotherapy and/or BCG on murine bladder cancer.
Soloway MS
Natl Cancer Inst Monogr; 1978 Dec; (49):327-32. PubMed ID: 748788
[TBL] [Abstract][Full Text] [Related]
23. Biochemical and pharmacologic study of therapeutic synergism with cyclophosphamide plus methotrexate in murine L1210 leukemia.
Klubes P; Cerna I
Cancer Treat Rep; 1981; 65(1-2):107-14. PubMed ID: 7226161
[TBL] [Abstract][Full Text] [Related]
24. Kinetic alterations induced by 5-fluorouracil in bone marrow, intestinal mucosa, and tumor.
Myers CE; Young RC; Chabner BA
Cancer Res; 1976 May; 36(5):1653-8. PubMed ID: 1268826
[TBL] [Abstract][Full Text] [Related]
25. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. X. Effect of treatment on tumor cell kinetics in mice.
Fisher B; Gunduz N
J Natl Cancer Inst; 1979 Jun; 62(6):1545-51. PubMed ID: 286125
[No Abstract] [Full Text] [Related]
26. Effects of combination drug therapy on the subcutaneous and pulmonary growth of a slow and a fast-growing C3H/He mammary carcinoma.
Vaage J; Costanza ME
Cancer Res; 1979 Nov; 39(11):4466-71. PubMed ID: 498077
[TBL] [Abstract][Full Text] [Related]
27. Effects of combination estrogen:cyclophosphamide treatment on the growth of the MXT transplantable mammary tumor in the mouse.
Markaverich BM; Medina D; Clark JH
Cancer Res; 1983 Jul; 43(7):3208-11. PubMed ID: 6850631
[TBL] [Abstract][Full Text] [Related]
28. Interleukin 1 alpha (IL-1) and macrophage colony-stimulating factor (M-CSF) accelerate recovery from multiple drug-induced myelosuppression.
Kovacs CJ; Kerr JA; Daly BM; Evans MJ; Johnke RM
Anticancer Res; 1998; 18(3A):1805-12. PubMed ID: 9673408
[TBL] [Abstract][Full Text] [Related]
29. Comparative toxicity of mitoxantrone and doxorubicin on hematopoietic stem cells.
OKunewick JP; Buffo MJ; Kociban DL
Exp Hematol; 1985; 13 Suppl 16():23-30. PubMed ID: 3987836
[TBL] [Abstract][Full Text] [Related]
30. Interleukin 1-induced sequential myelorestoration: dynamic relation between granulopoiesis and progenitor cell recovery in myelosuppressed mice.
Ido M; Harada M; Furuichi H; Matsuoka N; Nakano K; Sohmura Y
Exp Hematol; 1992 Feb; 20(2):161-6. PubMed ID: 1371964
[TBL] [Abstract][Full Text] [Related]
31. Combination of N,N',N"-triethylenethiophosphoramide and cyclophosphamide in vitro and in vivo.
Teicher BA; Holden SA; Cucchi CA; Cathcart KN; Korbut TT; Flatow JL; Frei E
Cancer Res; 1988 Jan; 48(1):94-100. PubMed ID: 3121169
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of C3H/He mouse mammary tumor growth by combined treatment with cyclophosphamide and polyadenylic-polyuridylic acid.
Youn JK; Lacour F; Hue G
Cancer Res; 1982 Nov; 42(11):4706-11. PubMed ID: 7127305
[TBL] [Abstract][Full Text] [Related]
33. Effects of double and multiple doses of hydroxyurea on mouse duodenum and mammary tumors.
Dethlefsen LA; Sorensen SP; Riley RM
Cancer Res; 1975 Mar; 35(3):694-9. PubMed ID: 1116130
[TBL] [Abstract][Full Text] [Related]
34. Effect of 3,5,3'-triiodo-L-thyronine on the incidence and growth kinetics of spontaneous mammary tumors in C3H/HeN mice.
Sellitti DF; Tseng YC; Latham KR
Cancer Res; 1981 Dec; 41(12 Pt 1):5015-9. PubMed ID: 7307003
[TBL] [Abstract][Full Text] [Related]
35. Site-dependent differences in response of the UV-2237 murine fibrosarcoma to systemic therapy with adriamycin.
Staroselsky AN; Fan D; O'Brian CA; Bucana CD; Gupta KP; Fidler IJ
Cancer Res; 1990 Dec; 50(24):7775-80. PubMed ID: 2253220
[TBL] [Abstract][Full Text] [Related]
36. Comparative effects of Corynebacterium parvum, Brucella abortus extract, Bacillus Calmette-Guérin, glucan, levamisole, and tilorone with or without cyclophosphamide on tumor growth, macrophage production, and macrophage cytotoxicity in a murine mammary tumor model.
Fisher B; Gebhardt M
Cancer Treat Rep; 1978 Nov; 62(11):1919-30. PubMed ID: 728912
[TBL] [Abstract][Full Text] [Related]
37. Effect of maltose tetrapalmitate on tumor vascularization and tumor growth.
Benrezzak O; Bissonnette E; Madarnas P; Nigam VN
Anticancer Res; 1989; 9(6):1815-8. PubMed ID: 2483306
[TBL] [Abstract][Full Text] [Related]
38. Adriamycin-induced delayed erythropoietic injury expressed following anemia stress.
Braunschweiger PG; Schenken LL; Schiffer LM
Cancer Res; 1980 Jul; 40(7):2257-62. PubMed ID: 7388791
[TBL] [Abstract][Full Text] [Related]
39. Effect of cyclophosphamide on the pathophysiology of RIF-1 solid tumors.
Braunschweiger PG
Cancer Res; 1988 Aug; 48(15):4206-10. PubMed ID: 3390814
[TBL] [Abstract][Full Text] [Related]
40. The effect of estrone-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors.
Janik P; Briand P; Hartmann NR
Cancer Res; 1975 Dec; 35(12):3698-704. PubMed ID: 1192428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
